JOURNAL ARTICLE

The transmembrane protease TMPRSS2 as a potential target for treatment of virus infection

Xiaoce Liu

Year: 2023 Journal:   Acta Crystallographica Section A Foundations and Advances Vol: 79 (a2)Pages: C1388-C1388

Abstract

TMPRSS2 is a member of the Type II Transmembran Serine Proteases (TTSPs) family, a critical tool for coronavirus and influenza virus entry into host cells [1][2][3].Here, we outline the essential role of the host serine protease TMPRSS2 in virus infection and focus on the development strategy of some potent inhibitors of TMPRSS2. . .

Keywords:
TMPRSS2 Virology Protease Virus Transmembrane protein Biology Computational biology Coronavirus disease 2019 (COVID-19) Medicine Genetics Internal medicine Enzyme Biochemistry

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.36
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Research on Leishmaniasis Studies
Health Sciences →  Medicine →  Public Health, Environmental and Occupational Health
interferon and immune responses
Life Sciences →  Immunology and Microbiology →  Immunology

Related Documents

JOURNAL ARTICLE

TMPRSS2 (transmembrane protease, serine 2)

Y Park

Journal:   Atlas of Genetics and Cytogenetics in Oncology and Haematology Year: 2011
JOURNAL ARTICLE

Transmembrane protease serine 2 (TMPRSS2)

Journal:   Science-Business eXchange Year: 2014 Vol: 7 (39)Pages: 1155-1155
JOURNAL ARTICLE

COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.

Jerzy Jankun

Journal:   Translation The University of Toledo Journal of Medical Sciences Year: 2020 Vol: 7 Pages: 1-5
© 2026 ScienceGate Book Chapters — All rights reserved.